Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on LinkedIn:
“I enjoyed asking Bob Weinberg at Massachusetts Institute of Technology a question after his wonderful seminar organized by Sendurai Mani at Brown University yesterday regarding the potential for breast cancer stem-like cells with hybrid EMT characteristics to interconvert among clinical breast cancer subtypes and whether this might be targeted in therapeutic design to decrease tumor aggressiveness.”
Other articles featuring Wafik S. El-Deiry on OncoDaily.